Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient

Clinical Pharmacology and Therapeutics

Volumn 68, Issue 1, 2000, Pages 98-103

  Masuda, Satohiro ^a   Uemoto, Shinji ^a   Hashida, Tohru ^a   Inomata, Yukihiro ^a   Tanaka, Koichi ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 3A4; GLYCOPROTEIN P; MESSENGER RNA; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; ILEUM GRAFT; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE CELL; LIVING DONOR; NEPHROTOXICITY; NEUROTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; ILEUM; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL ABSORPTION; MIXED FUNCTION OXYGENASES; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033863123     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.107912     Document Type: Article

References (18)

1. Living-related small bowel transplantation: The first case in Japan
2. Clinical pharmacokinetics of tacrolimus
3. Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations
4. The barrier function of CYP3A4 and P-glycoprotein in the small bowel
5. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole
6. Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers
7. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats
8. Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine
9. Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: Possible relationship to intestinal P-glycoprotein activity
10. Intestinal transplantation in composite visceral grafts or alone
11. A whole blood FK 506 assay for the IMX analyzer
12. Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay
13. Expression of cytochrome P 450 3A enzymes in human lung: A combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours
14. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells
15. Competitive PCR
16. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
17. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats
18. Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells